R. Šubert

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

Wolfram Pönisch, Paris S. Mitrou, K Merkle et al. · Journal of Cancer Research and Clinical Oncology · 2006 · 192 citations · Full text

Medicine, Hematology, Oncology +13

Weekly therapy with folinic acid (FA) and high-dose 5-fluorouracil (5-FU) 24-hour infusion in pretreated patients with metastatic colorectal carcinoma

H.J. Weh, H. Wilke, Judith Dierlamm et al. · Annals of Oncology · 1994 · 76 citations · Full text

Medicine, Oncology, Pharmacology +12

Intermediate-dose Cytarabine Treatment Delivered at Moderate Infusion Rates for De Novo Acute Myeloid Leukemia-Results of a phase I-II Study

Luisa Mantovani, Dirk Hasenclever, Rainer Krahl et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2002 · 10 citations

Medicine, Pharmacokinetics, Pharmacology +17